SCHEMBL763016

SCHEMBL763016

COCCCn1c([C@@H]2CCCN(C(=O)[C@@H]3CN(C(=O)OC(C)(C)C)C[C@H]3NC(=O)OCC3c4ccccc4-c4ccccc43)C2)nc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 3/20 0.41
MMP12 P39900 3/20 0.41
MMP3 P08254 2/20 0.41
MMP10 P09238 2/20 0.41
MMP8 P22894 2/20 0.41
HRH1 P35367 7/20 0.37
KCNH2 Q12809 4/20 0.37
CYP2D6 P10635 2/20 0.37
CHRM1 P11229 1/20 0.37
ADAM17 P78536 1/20 0.34
BACE1 P56817 1/20 0.34
USP30 Q70CQ3 1/20 0.34
HPGDS O60760 1/20 0.34
AGTR1 P30556 2/20 0.34
AGTR2 P50052 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762453 0.87 HRH1 (0.39) HRH1KCNH2CYP2D6CHRM1
Ammonia Solution, Strong SCHEMBL741029 0.86 HRH1 (0.39) HRH1KCNH2CYP2D6CHRM1
SCHEMBL742189 0.83 KCNH2 (0.38) HRH1KCNH2CYP2D6CHRM1BACE1
SCHEMBL742188 0.83 KCNH2 (0.38) HRH1KCNH2CYP2D6CHRM1BACE1
SCHEMBL763002 0.81 KCNH2 (0.38) HRH1KCNH2CYP2D6CHRM1
SCHEMBL741975 0.81 KCNH2 (0.52) HRH1KCNH2CYP2D6CHRM1HPGDS
SCHEMBL741974 0.81 KCNH2 (0.52) HRH1KCNH2CYP2D6CHRM1HPGDS
SCHEMBL742179 0.81 HRH1 (0.44) HRH1KCNH2CYP2D6CHRM1
SCHEMBL764341 0.79 HRH1 (0.41) HRH1KCNH2CYP2D6CHRM1
SCHEMBL762828 0.78 HRH1 (0.41) HRH1KCNH2CYP2D6CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed